Funder: Patient-Centered Outcomes Research Institute
Due Dates: September 23, 2025 (Letter of Intent) | January 13, 2026 (Full application)
Funding Amounts: Up to $12 million direct costs per project; up to 5 years; total program funds up to $60 million.
Summary: Supports rigorous, patient-centered comparative effectiveness research to improve care, symptom management, and diagnosis for rare diseases, emphasizing strong patient and stakeholder engagement.
Key Information: Projects focused solely on methods or new technology development are not eligible.